TELA Bio, Inc. (TELA) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Tela Bio, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.936 I would now like to turn the conference call over to Louisa Smith. 00:00:02.936 -- 00:00:06.418 Thank you, Martin. Please go ahead. 00:00:07.123 -- 00:00:09.587 Thank you, Kelvin, and good afternoon, everyone. 00:00:09.587 -- 00:00:16.398 Earlier today, Telebio released financial results for the third quarter of 2025. 00:00:16.398 -- 00:00:20.585 A copy of the press release is available on the company's website. 00:00:20.585 -- 00:00:25.642 Joining me on today's call are Tony Koblish, Chief Executive Officer, Jeff 00:00:25.642 -- 00:00:31.048 Blizzard, President, and Roberto Cuca, Chief Operating Officer and 00:00:31.048 -- 00:00:35.913 Chief Financial Officer. Before we begin, I'd like to remind you that during this conference 00:00:35.913 -- 00:00:40.398 call, the company may make projections and forward-looking statements regarding future 00:00:40.398 -- 00:00:46.224 events. We encourage you to review the company's past and future filings with the SEC, 00:00:46.224 -- 00:00:51.630 including, without limitation, the company's annual report on Form 10-K 00:00:51.630 -- 00:00:56.766 and quarterly reports on Form 10-Q, which identify the specific risk factors 00:00:56.766 -- 00:01:02.314 that may cause actual results or events to differ materially from those described 00:01:02.314 -- 00:01:07.821 in these forward-looking statements. These factors may include, without limitation, statements 00:01:07.821 -- 00:01:13.169 regarding product development and pipeline opportunities, product potential, the impact 00:01:13.169 -- 00:01:18.616 of various macroeconomic conditions identified in our filings, like changes in surgical 00:01:18.616 -- 00:01:23.827 procedural volumes, the regulatory environment, sales and marketing strategies, capita...